Global Kidney Cancer Market Research and Forecast 2018-2023

  • ID: 4471492
  • Report
  • Region: Global
  • Orion Market Research Private Limited
15 % OFF
until Dec 31st 2018
1 of 4

FEATURED COMPANIES

  • Abbvie Inc
  • ActuaTE Therapeutics Inc
  • Astrazeneca Plc
  • Cipla Limited
  • Exelixis, Inc.
  • Glaxosmithkline Plc
  • MORE
Kidney cancer is one of the most common cancers across the globe. Most of the kidney cancers get diagnosed before they metastasize to distant organs. However, the tumours can grow to be quite large before they are detected. The global kidney cancer market is estimated to grow with the CAGR of 6.2% during 2018-2023. The growth of the market is attributed to increasing incidence of kidney cancers and increasing ill lifestyle changes which gets worsen with addiction of tobacco and alcohol. Furthermore, overexposure to radiation during treatment testicular cancer, growing awareness program, and increasing mortality due to kidney cancer are boosting the kidney cancer market.

However, high cost associated with the treatment is the major restrain to the market. Generally, kidney cancer can cause in the range of $15,000 to $75,000. Various companies are getting FDA approval for kidney cancer and number of drugs is in clinical trial for the same. Hence innovation in drug development, and subsequent technological advancements & pipeline product finds an immense opportunity in near future.

On the basis of geography, the market has been divided into North America, Europe, Asia Pacific and Rest of the World. Europe is expected to dominate in the global kidney cancer market owing to high prevalence of kidney cancer in the UK, France, Germany and other EU countries. High prevalence of kidney cancer, high consumption of alcohol and tobacco are the major factor driving the market. North America and Asia Pacific are also expected to have a major market share during the forecast period. The major countries contributing in the APAC region are China, Australia, Japan and India. Large customer base, high consumption of Tabaco, continuous increment in economy and healthcare facility are the major factor for the growth of the market in the region. In North America, the US and Canada are expected to have a major market share in the region. As per National Cancer Institute kidney cancer is the 8th leading cancer in the US in 2017 with a share of around 4%.

A number of pharmaceutical companies are active in kidney cancer market. The major companies active in the market are Merck, Novartis, AstraZeneca, Bristol-Myers Squibb, Pfizer, Roche and so on. The companies are focusing on product innovations, expansions, M&A, finding new market or innovate in their core competency in order to expand individual market share. The report includes detailed market overview, strategic recommendations, key company analysis, key findings, analyst insights, market determinants, market segmentation and company profiling of the market.

Market Segmentation:

Global Kidney Cancer market is segmented on the basis of regional outlook and following segments:
  • Global Kidney Cancer Market Research and Analysis, By Cancer Type
  • Global Kidney Cancer Market Research and Analysis, By Cancer Cell
  • Global Kidney Cancer Market Research and Analysis, By Diagnosis
  • Global Kidney Cancer Market Research and Analysis, By Therapy
  • Global Kidney Cancer Market Research and Analysis, By Region
The Report covers:
  • Comprehensive research methodology of Global Kidney Cancer Market.
  • This report also includes detailed and extensive market overview with key analyst insights.
  • Exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
  • Analysis of regional regulations and other government policies impacting the
  • Global Kidney Cancer Market.
  • Insights about market determinants which are stimulating the Global Kidney Cancer Market.
  • Detailed and extensive market segments with regional distribution of forecasted revenues.
  • Extensive profiles and recent developments of market players.
READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Abbvie Inc
  • ActuaTE Therapeutics Inc
  • Astrazeneca Plc
  • Cipla Limited
  • Exelixis, Inc.
  • Glaxosmithkline Plc
  • MORE
1. Report Summary
1.1. Research Methods and Tools
1.2. Market Breakdown
1.2.1. by Segments
1.2.2. by Geography
1.2.3. by Stakeholders
1.2.4. Exceptions

2. Market Overview and Insights
2.1. Definition
2.2. Analyst Insights & Current Market Trends
2.2.1. Key Findings
2.2.2. Recommendation
2.2.3. Conclusion
2.3. Patent Analysis
2.4. Regulation
2.4.1.1. United States
2.4.1.2. European Union
2.4.1.3. China
2.4.1.4. India

3. Market Determinant
3.1. Motivators
3.1.1. High Prevalence of Kidney Cancer
3.1.2. Lifestyle Changes and Addiction of Tobocco and Other Harmful Substance
3.1.3. Over Exposure of Radiation During Testicular Cancer
3.1.4. Increasing Government Awareness Programs
3.1.5. R&D and Growing Government Grants and Funding
3.2. Restraints
3.2.1. High Cost Associated With Various Therapies
3.2.2. Unfavorable Reimbursement Policies
3.3. Opportunities
3.3.1. Innovation in Drug Development
3.3.2. Subsequent Technological Advancements & Growing Pipeline Products

4. Market Segmentation
4.1. Global Kidney Cancer Market, by Cancer Type
4.1.1. Renal Cell Carcinoma (Rcc)
4.1.2. Transitional Cell Cancer
4.1.3. Wilm's Tumour (Nephroblastoma)
4.1.4. Other (Sarcoma, Lymphoma)
4.2. Global Kidney Cancer Market, by Cancer Cell
4.2.1. Clear Cell
4.2.2. Papillary
4.2.3. Other (Chromophobe, Oncocytoma, Angiomyolipoma, Medullary, Sarcomatoid Features)
4.3. Global Kidney Cancer Market, by Diagnosis Method
4.3.1. Biopsy
4.3.2. Computed Tomography (Ct) Scan
4.3.3. Magnetic Resonance Imaging (Mri)
4.3.4. Ultrasound
4.4. Global Kidney Cancer Market, by Therapy
4.4.1. Surgery
4.4.2. Immunotherapy
4.4.3. Chemotherapy
4.4.4. Radiation Therapy
4.4.5. Cryotherapy

5. Competitive Landscape
5.1. Key Strategies
5.2. Key Company Analysis

6. Regional Analysis
6.1. North American
6.1.1. United States
6.1.2. Canada
6.2. Europe
6.2.1. UK
6.2.2. Germany
6.2.3. Spain
6.2.4. France
6.2.5. Italy
6.2.6. Rest of Europe
6.3. APAC
6.3.1. India
6.3.2. China
6.3.3. Japan
6.3.4. Rest of APAC
6.4. Rest of the World

7. Company Profiles
7.1. Abbvie Inc
7.2. Active Biotech Ab
7.3. Actuate Therapeutics Inc
7.4. Adaptimmune Therapeutics PLC
7.5. Amgen Inc
7.6. Astrazeneca PLC
7.7. Bayer Pharma Ag
7.8. Cipla Limited
7.9. Eisai Co., Ltd.
7.10. Exelixis, Inc.
7.11. Genentech, Inc.
7.12. Glaxosmithkline PLC
7.13. Hoffman-La Roche
7.14. Jazz Pharmaceuticals, Inc.
7.15. Merck & Co.
7.16. Novartis Ag
7.17. Onyx
7.18. Pfizer Inc.
7.19. Prometheus Laboratories Inc
7.20. Sanofi
7.21. Takeda Pharmaceutical Company Limited

List of Tables:
Table 1 Global Kidney Cancer Market Research and Analysis, by Cancer Type 2017-2023 ($ Million)
Table 2 Global Renal Cell Carcinoma (Rcc) Kidney Cancer Market Research and Analysis, 2017-2023 ($ Million)
Table 3 Global Transitional Cell Cancer Market Research and Analysis, 2017-2023 ($ Million)
Table 4 Global Wilm's Tumour Market Research and Analysis, 2017-2023 ($ Million)
Table 5 Global Other Kidney Cancer Market Research and Analysis, 2017-2023 ($ Million)
Table 6 Global Kidney Cancer Market Research and Analysis, by Cancer Cell 2017-2023 ($ Million)
Table 7 Global Clear Cell Kidney Cancer Market Research and Analysis, 2017-2023 ($ Million)
Table 8 Global Papillary Kidney Cancer Market Research and Analysis, 2017-2023 ($ Million)
Table 9 Global Other Kidney Cancer Cell Market Research and Analysis, 2017-2023 ($ Million)
Table 10 Global Kidney Cancer Market Research and Analysis, by Diagnosis Method 2017-2023 ($ Million)
Table 11 Global Kidney Cancer Biopsy Market Research and Analysis, 2017-2023 ($ Million)
Table 12 Global Kidney Cancer Computed Tomography (Ct) Scan Market Research and Analysis, 2017-2023 ($ Million)
Table 13 Global Kidney Cancer Magnetic Resonance Imaging (Mri) Market Research and Analysis, 2017-2023 ($ Million)
Table 14 Global Kidney Cancer Ultrasound Market Research and Analysis, 2017-2023 ($ Million)
Table 15 Global Kidney Cancer Market Research and Analysis, 2017-2023 ($ Million)
Table 16 Global Kidney Cancer Surgery Market Research and Analysis, by Therapy 2017-2023 ($ Million)
Table 17 Global Kidney Cancer Immunotherapy Market Research and Analysis, 2017-2023 ($ Million)
Table 18 Global Kidney Cancer Chemotherapy Market Research and Analysis, 2017-2023 ($ Million)
Table 19 Global Kidney Cancer Radiation Therapy Market Research and Analysis, 2017-2023 ($ Million)
Table 20 Global Kidney Cancer Cryotherapy Market Research and Analysis, 2017-2023 ($ Million)
Table 21 North America Kidney Cancer Market Research and Analysis, by Cancer Type, 2017-2023 ($ Million)
Table 22 North America Kidney Cancer Market Research and Analysis, by Diagnosis Method 2017-2023 ($ Million)
Table 23 North America Kidney Cancer Market Research and Analysis, by Therapy 2017-2023 ($ Million)
Table 24 North America Kidney Cancer Market Research and Analysis, by Cancer Cell, 2017-2023 ($ Million)
Table 25 North America Kidney Cancer Market Research and Analysis, by Countries 2017-2023 ($ Million)
Table 26 Europe Kidney Cancer Market Research and Analysis, by Cancer Type, 2017-2023 ($ Million)
Table 27 Europe Kidney Cancer Market Research and Analysis, by Diagnosis Method 2017-2023 ($ Million)
Table 28 Europe Kidney Cancer Market Research and Analysis, by Therapy 2017-2023 ($ Million)
Table 29 Europe Kidney Cancer Market Research and Analysis, by Cancer Cell 2017-2023 ($ Million)
Table 30 Europe Kidney Cancer Market Research and Analysis, by Countries 2017-2023 ($ Million)
Table 31 Asia Pacific Kidney Cancer Market Research and Analysis, by Cancer Type, 2017-2023 ($ Million)
Table 32 Asia Pacific Kidney Cancer Market Research and Analysis, by Diagnosis Method 2017-2023 ($ Million)
Table 33 Asia Pacific Kidney Cancer Market Research and Analysis, by Therapy 2017-2023 ($ Million)
Table 34 Asia Pacific Kidney Cancer Market Research and Analysis, by Cancer Cell 2017-2023 ($ Million)
Table 35 Asia Pacific Kidney Cancer Market Research and Analysis, by Countries 2017-2023 ($ Million)

List of Figures:
Figure 1 Global Kidney Cancer Market Share, by Cancer Type 2017 vs 2023 ($ Million)
Figure 2 Global Kidney Cancer Market Share, by Diagnostic Method 2017 vs 2023 ($ Million)
Figure 3 Global Kidney Cancer Market Share, by Therapy 2017 vs 2023 ($ Million)
Figure 4 Global Kidney Cancer Market Share, by Cancer Cell 2017 vs 2023 ($ Million)
Figure 5 Global Kidney Cancer Market Share, by Geography 2017 vs 2023 ($ Million)
Figure 6 North America Kidney Cancer Market Share, 2017-2023($ Million)
Figure 7 United States Kidney Cancer Market Research and Analysis, 2017-2023 ($ Million)
Figure 8 Canada Market Kidney Cancer Research and Analysis, 2017-2023 ($ Million)
Figure 9 Europe Market Research and Analysis, 2017-2023($ Million)
Figure 10 UK Kidney Cancer Market Research and Analysis, 2017-2023 ($ Million)
Figure 11 Germany Kidney Cancer Market Research and Analysis, 2017-2023 ($ Million)
Figure 12 Spain Kidney Cancer Market Research and Analysis, 2017-2023 ($ Million)
Figure 13 France Kidney Cancer Market Research and Analysis, 2017-2023 ($ Million)
Figure 14 Italy Kidney Cancer Market Research and Analysis, 2017-2023 ($ Million)
Figure 15 ROE Kidney Cancer Market Research and Analysis, 2017-2023 ($ Million)
Figure 16 Asia Pacific Market Research and Analysis, 2017-2023($ Million)
Figure 17 China Kidney Cancer Market Research and Analysis, 2017-2023 ($ Million)
Figure 18 India Kidney Cancer Market Research and Analysis, 2017-2023 ($ Million)
Figure 19 Japan Kidney Cancer Market Research and Analysis, 2017-2023 ($ Million)
Figure 20 Rest of Asia Pacific (RoAPAC) Kidney Cancer Market Research and Analysis, 2017-2023 ($ Million)
Figure 21 Rest of World (Row) Kidney Cancer Market Research and Analysis, 2017-2023 ($ Million)
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Abbvie Inc
  • Active Biotech Ab
  • ActuaTE Therapeutics Inc
  • Adaptimmune Therapeutics Plc
  • Amgen Inc
  • Astrazeneca Plc
  • Bayer Pharma Ag
  • Cipla Limited
  • Eisai Co., Ltd.
  • Exelixis, Inc.
  • Genentech, Inc.
  • Glaxosmithkline Plc
  • Hoffman-La Roche
  • Jazz Pharmaceuticals, Inc.
  • Merck & Co.
  • Novartis Ag
  • Onyx
  • Pfizer Inc.
  • Prometheus Laboratoriesinc
  • Sanofi
  • Takeda Pharmaceutical CoMPany Limited
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll